Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin (ROSES)
Type 2 Diabetes

About this trial
This is an interventional treatment trial for Type 2 Diabetes focused on measuring Diabetes, Self monitoring blood glucose
Eligibility Criteria
Inclusion Criteria:
- Patients with Type 2 diabetes (known diabetes or new diagnosis) seen for the first time in the diabetes outpatient clinic;
- Patients on treatment with OHA monotherapy (i.e. metformin alone or sulphonylureas alone or TZDs alone);
- No need for insulin treatment;
- Male and female patients, aged between 45-75 years;
- Hba1c values between 7% and 9% included (considering a value of 6.0% as the upper limit of normal value)
- No experience of self monitoring of blood glucose in the previous 12 months (SMBG performed with a frequency of < 1 times/week)
- Ability and willingness to comply with all study requirements
- Signature of consent form
Exclusion Criteria:
- Patients incapable to perform SMBG
- Patients needing insulin or multiple OHA association therapy
- Patients needing a regular use of SMBG (e.g. frequent hypoglycemic episodes)
- Diabetes care not exclusively managed by diabetic clinics
- Patients with serious underlying medical or psychiatric condition
Sites / Locations
- Consorzio Mario Negri Sud
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
SMBG + intensive education
Usual Care
Patients will receive specific educational interventions to teach them how to perform Self monitoring Blood Glucose (SMBG), how to modify diet and level of physical activity according to blood glucose levels, and the actions to be undertaken in case of abnormal values (hypoglycemia, particularly elevated glucose levels). Patients will be instructed to modify their lifestyle habits (diet, physical activity) in order to reach specific goals (weight reduction, reduction in fat consumption intake, reduction in saturated fat intake, increase in fiber intake, regular physical activity.
Usual Care